Jack Badaracco

Articles by Jack Badaracco

37 Estimating the Direct and Indirect Resource Burden of Treatment Management With Current Standard of Care or Elacestrant for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer Patients: A Population- Level Provider Model

37 Estimating the Direct and Indirect Resource Burden of Treatment Management With Current Standard of Care or Elacestrant for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer Patients: A Population- Level Provider Model

ByGregory Vidal, MD, PhD,Frank Cinfio,Jack Badaracco,Corey Pelletier,Matthew Gitlin

June 22nd 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Talazoparib/Enzalutamide for HRR Gene-Altered Metastatic Prostate Cancer

Ivonescimab Combo Improves Survival in Advanced Biliary Tract Cancer

Osimertinib/Savolitinib Improves Survival in MET-Altered EGFR-Mutant NSCLC

Exploring The Use of GLP-1 Receptor Agonists in Breast Cancer Care

Sac-TMT Improves Survival vs Chemotherapy in Pretreated Endometrial Cancer